Our innovative Drug Delivering Technologies result in several benefits for patients:

Improved Medication Adherence:Lack of patient adherence to the medication has a major impact on the treatment outcomes. In certain disease areas (such as schizophrenia and other mental illnesses) improving patient adherence is a well recognized unmet medical need, which can substantially reduce relapses and increase overall treatment success.

Patient Convenience: Most biopharmaceuticals can only be administered by painful subcutaneous injections. Our Drug Delivery Systems eliminate the need for painful injections, offering patients an alternative that is easier, more convenient, and less invasive. Offering a convenient way to deliver proteins and peptides can provide key differentiation in the large but crowded space of biopharmaceuticals. It also improves the patient’s experience and increases the patient’s willingness to take the medication.

Improved Safety and Efficacy: Peak plasma levels of a drug are usually associated with more AEs, whereas lack of efficacy is typically linked to drug levels that are subtherapeutic. The pharmacokinetic profile of most drugs is not very smooth and often includes peaks which lead to AEs, as well as subtherapeutic troughs. Our sustained release technologies result in a smooth PK profile where the drug level stays within the therapeutic window for several months. Maintaining the appropriate PK level allows us to achieve enhanced efficacy while using a lower dose of the drug and thus improving safety.

Cost Efficiency: Cost efficiency is not just about the price of healthcare resources (medications, facilities, etc), but also about the usage of these resources. At a time when the United States and many other countries are trying to manage healthcare costs, most of the emphasis is placed on improving the system’s efficiency, instead of reducing its overall usage. At Delpor, we believe that increasing treatment success and reducing the need for physician involvement is another key way of managing healthcare costs.

Enabling Drug Development: There are several drugs that have tremendous therapeutic potential, but face considerable delivery challenges. Examples include certain peptides that are very potent but are cleared rapidly from the human body. Our technologies can enable the sustained or pattern specific release of drugs for several months. Such delivery can be essential in many cases in order to allow certain agents to achieve their therapeutic potential.

Comments are closed.